EBIT: Income before interest and taxes.
Psyence Biomedical Ltd. (PBM) had EBIT of $-1.51M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.75M |
|
-- |
|
-- |
|
$1.51M |
|
$-1.51M |
|
$0.75M |
|
$-0.75M |
|
$-0.75M |
|
$-0.75M |
|
$-0.75M |
|
$-0.75M |
|
$-0.75M |
|
|
EBIT |
$-1.51M |
$-1.51M |
|
0.24M |
|
0.24M |
|
$-3.19 |
|
$-3.19 |
|
| Balance Sheet Financials | |
$7.63M |
|
$0.01M |
|
$5.18M |
|
$12.81M |
|
$0.94M |
|
-- |
|
-- |
|
$0.94M |
|
$11.87M |
|
$11.87M |
|
$11.87M |
|
0.30M |
|
| Cash Flow Statement Financials | |
$-2.03M |
|
$-4.01M |
|
$7.06M |
|
$6.14M |
|
$7.15M |
|
$1.01M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.35% |
|
-6.35% |
|
-5.88% |
|
-6.35% |
|
$39.62 |
|
$-8.56 |
|
$-8.56 |
|